1. Home
  2. PYPD vs LSE Comparison

PYPD vs LSE Comparison

Compare PYPD & LSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PolyPid Ltd.

PYPD

PolyPid Ltd.

N/A

Current Price

$5.10

Market Cap

71.7M

Sector

Health Care

ML Signal

N/A

Logo Leishen Energy Holding Co. Ltd. Ordinary Shares

LSE

Leishen Energy Holding Co. Ltd. Ordinary Shares

N/A

Current Price

$5.60

Market Cap

88.5M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
PYPD
LSE
Founded
2008
2007
Country
Israel
China
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Metal Fabrications
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
71.7M
88.5M
IPO Year
2014
2023

Fundamental Metrics

Financial Performance
Metric
PYPD
LSE
Price
$5.10
$5.60
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
$12.25
N/A
AVG Volume (30 Days)
169.7K
5.8K
Earning Date
05-06-2026
01-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$61.76
Revenue Growth
N/A
N/A
52 Week Low
$3.06
$3.20
52 Week High
$5.73
$6.98

Technical Indicators

Market Signals
Indicator
PYPD
LSE
Relative Strength Index (RSI) 58.99 64.18
Support Level $4.18 $3.97
Resistance Level $5.07 $6.92
Average True Range (ATR) 0.25 0.37
MACD 0.06 0.08
Stochastic Oscillator 83.80 83.11

Price Performance

Historical Comparison
PYPD
LSE

About PYPD PolyPid Ltd.

PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. The company's product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.

About LSE Leishen Energy Holding Co. Ltd. Ordinary Shares

Leishen Energy Holding Co Ltd is a provider of clean-energy equipment and integrated solutions to the oil and gas industry, with a commitment to providing customers with high-performance, safe, and cost-effective energy solutions. The company's business segments include clean-energy equipment, oil and gas engineering technical services, new energy production and operation, and digitalization and integration equipment. A majority of its revenue is generated from the clean-energy equipment segment, which supplies various equipment, such as reciprocating compressor units, expansion units, wellhead heating systems, wellhead safety control systems, oil-water separation systems, natural gas online sampling systems, oil and gas skid-mounted equipment, and polymer flexible composite pipes.

Share on Social Networks: